Search Results - "Hogan, K T"

Refine Results
  1. 1

    The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated Elongation Factor 2 gene by HOGAN, K. T, EISINGER, D. P, CUPP, S. B, LEKSTROM, K. J, DEACON, D. D, SHABANOWITZ, J, HUNT, D. F, ENGELHARD, V. H, SLINGLUFF, C. L, ROSS, M. M

    Published in Cancer research (Chicago, Ill.) (15-11-1998)
    “…The identification of naturally processed tumor peptides that can stimulate a tumor-specific, CTL response is crucial to the development of a vaccine-based,…”
    Get full text
    Journal Article
  2. 2

    Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3 by Hogan, KT, Clayberger, C, Bernhard, EJ, Walk, SF, Ridge, JP, Parham, P, Krensky, AM, Engelhard, VH

    Published in The Journal of immunology (1950) (01-10-1988)
    “…Site-directed mutagenesis of HLA-A2.1 has been used to identify the amino acid substitutions in HLA-A2.3 that are responsible for the lack of recognition of…”
    Get full text
    Journal Article
  3. 3

    The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity by Bernhard, EJ, Le, AX, Yannelli, JR, Holterman, MJ, Hogan, KT, Parham, P, Engelhard, VH

    Published in The Journal of immunology (1950) (01-12-1987)
    “…Two groups of human and murine cytotoxic T lymphocyte (CTL) clones specific for human leukocyte antigen (HLA)-A2 or -B7 can be distinguished based on their…”
    Get full text
    Journal Article
  4. 4

    Localization and characterization of serologic epitopes on HLA-A2 by Hogan, K T, Brown, S L

    Published in Human immunology (01-03-1992)
    “…A panel of cells expressing 68 different mutant HLA-A2 genes was generated by site-directed mutagenesis and DNA-mediated gene transfer in order to define the…”
    Get more information
    Journal Article
  5. 5

    Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes by Teng, J M, Hogan, K T

    Published in Molecular immunology (01-04-1994)
    “…An examination of the crystal structure of HLA-A2.1 reveals two classes of residues on the class I MHC molecule that could affect CTL recognition: (1) those…”
    Get more information
    Journal Article
  6. 6

    Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members by HOGAN, Kevin T, SUTTON, Jennifer N, CHU, Kyo U, BUSBY, Jennifer A. C, SHABANOWITZ, Jeffrey, HUNT, Donald F, SLINGLUFF, Craig L

    Published in Cancer Immunology, Immunotherapy (01-04-2005)
    “…The development of peptide-based vaccines that are useful in the therapeutic treatment of melanoma and other cancers ultimately requires the identification of…”
    Get full text
    Journal Article
  7. 7

    A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes by Hogan, KT, Clayberger, C, Bernhard, EJ, Walk, SF, Ridge, JP, Parham, P, Krensky, AM, Engelhard, VH

    Published in The Journal of immunology (1950) (15-03-1989)
    “…HLA-A2.1 and HLA-A2.3, which differ from one another at residues 149, 152, and 156, can be distinguished by the mAb CR11-351 and many allogeneic and xenogeneic…”
    Get full text
    Journal Article
  8. 8

    Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule by Hogan, KT, Clayberger, C, Le, AX, Walk, SF, Ridge, JP, Parham, P, Krensky, AM, Engelhard, VH

    Published in The Journal of immunology (1950) (01-12-1988)
    “…Hemi-exon shuffling and site-directed mutagenesis have been used to determine which amino acid differences between HLA-A2.1 and HLA-A2.2 alter the CTL-defined…”
    Get full text
    Journal Article
  9. 9

    Clonal analysis of the cytotoxic T-lymphocyte response to reovirus by Hogan, K T, Cashdollar, L W

    Published in Viral immunology (1991)
    “…Reovirus has previously been classified into three serotypes based on hemagglutination inhibition assays. In the present study, the specificity of cytotoxic T…”
    Get more information
    Journal Article
  10. 10
  11. 11

    A Class I MHC-Restricted Recall Response to a Viral Peptide Is Highly Polyclonal Despite Stringent CDR3 Selection: Implications for Establishing Memory T Cell Repertoires in "Real-World" Conditions by Naumov, Yuri N, Hogan, Kevin T, Naumova, Elena N, Pagel, Jeminah T, Gorski, Jack

    Published in The Journal of immunology (1950) (15-03-1998)
    “…In this study, we analyze the recall response to influenza A matrix peptide M1(58-66) restricted by HLA-A2 in one individual and find a strict CDR3 selection…”
    Get full text
    Journal Article
  12. 12

    The reovirus nonstructural protein sigma1NS is recognized by murine cytotoxic T lymphocytes by Hoffman, L M, Hogan, K T, Cashdollar, L W

    Published in Journal of Virology (01-11-1996)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13

    Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytes by Hogan, Kevin T., Coppola, Michael A., Gatlin, Christine L., Thompson, Lee W., Shabanowitz, Jeffrey, Hunt, Donald F., Engelhard, Victor H., Slingluff, Craig L., Ross, Mark M.

    Published in Immunology letters (15-12-2003)
    “…We previously established a melanoma-reactive cytotoxic T lymphocyte (CTL) line that recognizes multiple epitopes in the context of HLA-A3. To increase the…”
    Get full text
    Journal Article
  14. 14

    Identification of class I MHC regions which bind to the adenovirus E3-19k protein by Flomenberg, P, Gutierrez, E, Hogan, K T

    Published in Molecular immunology (01-11-1994)
    “…The adenovirus early region 3 glycoprotein E3-19k binds to and inhibits expression of class I major histocompatibility complex (MHC)-encoded molecules, which…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide by Hogan, K T, Shimojo, N, Walk, S F, Engelhard, V H, Maloy, W L, Coligan, J E, Biddison, W E

    Published in The Journal of experimental medicine (01-08-1988)
    “…Previous studies have suggested that MHC class I molecules bind and present peptides to CTL in a manner that is analogous to the presentation of peptides by…”
    Get full text
    Journal Article
  17. 17

    HLA (A0201) Mimicry by Anti-Idiotypic Monoclonal Antibodies by Burlingham, William J, Jankowska-Gan, Ewa, DeVito-Haynes, Lynn, Fechner, John H., Jr, Hogan, Kevin T, Claas, Frans H. J, Mulder, Arend, Wang, Xinhui, Ferrone, Soldano

    Published in The Journal of immunology (1950) (15-12-1998)
    “…Soluble MHC Ags and anti-Id (anti-anti-MHC) Abs have both been shown to inhibit MHC alloantigen-specific B cell responses in vivo. We hypothesized that some…”
    Get full text
    Journal Article
  18. 18

    Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes by Teng, J M, Hogan, K T

    Published in Molecular immunology (01-04-1994)
    “…Most of the polymorphic residues in class I MHC molecules are concentrated in the alpha 1- and alpha 2-domains with their side chains pointing towards the…”
    Get more information
    Journal Article
  19. 19

    Suppression of polyclonal, tumor cell and alloantigen-induced proliferation: identification of cyclooxygenase pathway dependent and independent mechanisms by Hogan, K T, Hollingsworth, M A, Seymour, 3rd, R E, Quinn, M K, Evans, D L

    Published in Immunopharmacology (01-02-1984)
    “…Polyclonal T cell activation, syngeneic tumor cell and alloantigen-induced proliferative responses were studied to determine if the regulation of these…”
    Get more information
    Journal Article
  20. 20

    Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127 by De Vito, L D, Mason, B P, Jankowska-Gan, E, Hogan, K T, Guo, J W, Lutz, C T, Sollinger, H W, Burlingham, W J

    Published in Human immunology (01-07-1993)
    “…Anti-HLA-A2 CREG antibodies were purified from seven individuals by affinity chromatography. The binding of the purified antibodies to single or multiple amino…”
    Get more information
    Journal Article